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Objectives: Major depression is common in elderly patients. Interpersonal psychotherapy
(IPT) is a potentially effective treatment for depressed elderly patients. The objective of
this study was to evaluate the cost-effectiveness of IPT delivered by mental health
workers in primary care practices, for depressed patients 55 years of age and older
identified by screening, in comparison with care as usual (CAU).
Methods: We conducted a full economic evaluation alongside a randomized controlled
trial comparing IPT with CAU. Outcome measures were depressive symptoms, presence
of major depression, and quality of life. Resource use was measured from a societal
perspective over a 12-month period by cost diaries. Multiple imputation and bootstrapping
were used to analyze the data.
Results: At 6 and 12 months, the differences in clinical outcomes between IPT and CAU
were small and nonsignificant. Total costs at 12 months were €5,753 in the IPT group and
€4,984 in the CAU group (mean difference, €769; 95 percent confidence interval,
−2,459 – 3,433). Cost-effectiveness planes indicated that there was much uncertainty
around the cost-effectiveness ratios.
Conclusions: Based on these results, provision of IPT in primary care to elderly
depressed patients was not cost-effective in comparison to CAU. Future research should
focus on improvement of patient selection and treatments that have more robust effects in
the acute and maintenance phase of treatment.
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Psychotherapy
Major depression is a common disorder in elderly people with
the 1-month prevalence ranging from 2.0 percent in the com-
munity to 8.7 percent in primary care (2;5). Major depression
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in the elderly is associated with physical disability, impaired
well-being, and high health service use and healthcare costs
(4;11;22;29;37). Thus, it is important to have effective treat-
ments for elderly depressed patients.
Antidepressant treatment is usually initiated as the
first line of treatment, but may induce substantial side ef-
fects. Moreover, many patients prefer psychotherapy over
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antidepressant medication (40). Psychotherapy is mainly pro-
vided in specialized mental health clinics, but many older
depressed patients are reluctant to accept treatment in such
clinics (3). Therefore, psychotherapy should be made more
easily available in primary care.
Interpersonal Psychotherapy (IPT) is recommended by
several depression treatment guidelines (1;30). The format
of IPT is suitable for elderly patients (23), and there is ev-
idence that IPT is effective in the treatment of depressed
elderly patients (15;41). Considering the increased health-
care costs associated with major depression in elderly people
(11;22;37), it is important to have information on the cost-
effectiveness of IPT in this group of patients. Lave et al. (21)
found that IPT was associated with significantly greater ef-
fects and significantly higher costs in comparison with usual
care in relatively young adults. We are not aware of any trials
evaluating the cost-effectiveness of IPT in elderly primary
care patients with major depression.
The objective of this article was to evaluate the cost-
effectiveness of IPT delivered by mental health workers in
primary care practices, for elderly patients with major de-
pression identified by screening, in comparison with usual
general practitioner (GP) care. The economic evaluation was
conducted alongside a randomized controlled trial. Overall,
the treatment effects of IPT at 6 months were modest in this
trial and more pronounced in the subgroup of patients with
more severe depression at baseline (41).
METHODS
The randomized controlled trial was performed in twelve
general practices in Amsterdam and surroundings, The
Netherlands. The Medical Ethical Committee of the VU
University Medical Center approved the study protocol. The
methodological details of the trial are reported elsewhere
(41).
Patient Selection
Patients were recruited from February 2002 to July 2003
using a two-stage screening procedure. Patients of 55 years
and older who had recently visited their GP, were invited
by mail to complete the fifteen-item version of the Geriatric
Depression Scale (GDS-15) (34). Patients with a GDS-15
score of 5 or more were invited by a research assistant for
further diagnostic examination. After consent, the research
assistant administered the mood module of the PRIMary care
Evaluation of Mental Disorders (PRIME-MD) (35). Patients
who were diagnosed with major depression according to the
PRIME-MD were eligible for the study. Exclusion criteria
were treatment for depression at the time of screening, insuf-
ficient understanding of the Dutch language, and impaired
cognitive functioning (Mini-Mental State Examination score
<18). Randomization was performed by an independent re-
search assistant at patient level using blocking by practice
(blocks of four) and a table of random numbers.
Care as Usual Group
GPs were not notified about patient participation in the care
as usual (CAU) group of the study. Patients who wanted
treatment for their depression were advised to discuss this
with their GP. Dutch GPs are encouraged to work according
to the guidelines issued by the Dutch College of GPs (39).
However, they are free to deviate from these guidelines and
to organize care according to their own views.
Psychotherapy Group
IPT is a manual-based, time-limited therapy, with a focus on
current interpersonal relationships (42). Six psychologists
and nine psychiatric nurses provided IPT. All therapists were
trained in a 2-day course, followed by group supervision
sessions once every 2 weeks during a year, after which the
frequency was reduced to once a month.
Patients were offered ten sessions of IPT over a period
of 5 months. GPs of patients in the IPT group were asked
to refrain from prescription of antidepressants and referral to
other mental healthcare providers.
Clinical Outcome Measures
Trained, independent interviewers measured outcomes dur-
ing interviews at 2, 6, and 12 months after baseline. Re-
mission of depression was defined as a Montgomery Asberg
Depression Rating Scale (MADRS) score of less than 10
(16;25). Response to treatment was defined as a decrease of
more than 50 percent in MADRS score at 12 months com-
pared with baseline. The MADRS was also used to assess
changes in severity of depression. Recovery from depres-
sion was defined as absence of a PRIME-MD diagnosis of
major depression at 12 months. Quality-adjusted life-years
(QALYs) gained at 12 months follow-up were calculated by
multiplying the time a patient spent in a particular health state
with the utility based on EuroQol scores using Dutch and
British tariffs (13;14;20). Transitions between health states
were linearly interpolated.
Cost Measures
Cost data were collected from a societal perspective over
12 months using cost diaries. All direct and indirect costs
were considered, because it is very hard to discern which
costs are depression-related and which are not. If available,
Dutch guideline prices were used to value resource use (28).
Supplemental Table 1, listing the cost categories included
in the economic evaluation and the prices used, is avail-
able at http://www.journals.cambridge.org/jid_thc. Medica-
tion costs were valued using prices of the Royal Dutch So-
ciety for Pharmacy (43). Costs of complementary medicine
visits were based on prices from therapists. All costs were ad-
justed to the year 2003 using consumer price indices (36). We
calculated the costs of absenteeism from paid work accord-
ing to the friction cost approach (friction period 123 days)
using the mean age- and sex-specific income of the Dutch
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population (19). A cost price for IPT was calculated using
a bottom-up approach (Supplemental Table 2, available at
http://www.journals.cambridge.org/jid_thc).
Analysis
It was estimated that sixty patients per group were needed
(α = .05 and β = .80) to detect a difference in remission
of 25 percent. Taking 10 percent dropout into account, a
total of 140 patients should be included. All analyses were
performed according to the intention-to-treat principle. To
get an impression of the depression-related costs, patients
were asked to indicate whether resource use or absenteeism
was related to their depression. In a secondary analysis, only
depression-related costs at 12 months were included.
Multiple imputation (MI) was used to impute missing
cost and effect data using the Multivariate Imputation by
Chained Equations (MICE) procedure (38). To account for
the non-normal cost distributions, cost data were imputed af-
ter log transformation and back transformed to their original
scale after imputation. By MI, ten imputed data sets were
created, each of which were analyzed separately. The results
of the ten analyses were combined using Rubin’s rules to pro-
duce pooled estimates of mean costs and effects, mean costs
and effect differences, standard deviations, and confidence
intervals (CIs) (32).
Confidence intervals for the mean differences in costs
and uncertainty around the cost-effectiveness and cost–utility
ratios were calculated using the percentile bootstrap method
based on 2000 replications (10). The bootstrapped cost-
effect pairs in the pooled data set were plotted on a cost-
effectiveness plane.
RESULTS
Between February 2002 and July 2003, 4,301 of 6,719 pa-
tients completed the GDS-15, of whom 834 screened pos-
itive. The PRIME-MD was completed by 667 patients of
whom 293 patients had major depression. Of these, 88 were
ineligible, mainly because of ongoing depression treatment.
Of the 205 eligible patients, 143 agreed to participate in the
trial. Sixty-nine patients were allocated to the IPT group
and seventy-four patients to the CAU group. In total, 59
percent of the cost diaries was returned. Patients who re-
turned no cost diaries were less depressed according to the
MADRS than patients who returned one or more cost di-
aries. At baseline, there were no significant differences in pa-
tient characteristics between IPT patients and CAU patients
(Supplemental Table 3, available at http://www.journals.
cambridge.org/jid_thc).
Clinical Effectiveness
At 6 and 12 months, differences in remission and response
rates based on the MADRS score were small and not sta-
tistically significant. Although patients in the IPT group im-
proved somewhat more in MADRS score than patients in the
CAU group both at 6 and 12 months, these differences were
not statistically significant (Table 1).
At 6 months, 42 (60 percent) of the IPT patients and 31
(42 percent) of the CAU patients had recovered according to
the PRIME-MD. The difference in recovery rate just failed to
reach statistical significance (95 percent CI, −0.22 – 37.8).
At 12 months of follow-up, the recovery rate in the IPT group
was 45 percent (31 recovered patients) and also 45 percent
in the CAU group (33 recovered patients). The difference in
recovery rate at 12 months was not statistically significant
(Table 1).
The estimates of mean QALYs gained based on the
Dutch tariff were somewhat higher than the estimates based
on the British tariff. The difference in QALYs gained between
the IPT and the CAU group was small and not statistically
significant, and similar for both tariffs at both time points
(Table 1).
Costs
IPT patients received on average eight IPT sessions, which
amounted to a mean cost of €656. Direct healthcare costs
were the greatest contributor to total costs, followed by lost
productivity costs due to work absenteeism at both 6 and
12 months. The great impact of lost productivity costs is re-
markable, because more than half of the study patients were
older than the pensionable age of 65 years in The Nether-
lands. At 6 and 12 months, mean total costs were, respec-
tively, €1,077 and €769 higher in the IPT group, but these
differences were not statistically significant. The costs of
providing IPT formed a considerable part of the direct costs
in the IPT group both at 6 months (44 percent) and at 12
months (16 percent) (Tables 2 and 3).
Cost-Effectiveness and Cost–Utility
Analyses
The cost-effectiveness plane for remission based on MADRS
score after 6 months showed that IPT was not cost-effective
in comparison with CAU. After 12 months, the IPT group
experienced 6 percent less remissions based on MADRS
score than the CAU group, whereas total costs were on
average €769 higher, resulting in a negative incremental
cost-effectiveness ratio (ICER) of −131. The nonsignificant
differences in costs and effects were confirmed by the
cost-effectiveness plane, in which most cost-effect pairs
were located near the origin and distributed over all four
quadrants (NE, 16 percent; SE, 7 percent; SW, 21 percent;
NW, 56 percent).
At 6 months, the IPT group experienced 19 percent
more recoveries based on the PRIME-MD than the CAU
group, while the mean total costs in the IPT group were
€1,077 higher than in the CAU group. Thus, the ICER was
€57 per 1 percent improvement in the number of recov-
ered patients based on the PRIME-MD, which translates to
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Table 1. Clinical Outcomes after 6 and 12 Months
Outcome measure IPT (n = 69) CAU (n = 74) Difference (95% CI)
MADRS remissiona
6 months 32.2% (47.0) 30.8% (46.4) 1.4 ( −14.8 – 17.5)
12 months 28.8% (45.6) 34.7% (47.9) −5.8 (−22.5 – 10.7)
MADRS responsea
6 months 25.8% (44.0) 27.3% (44.8) −1.5 (−17.1 – 14.1)
12 months 27.1% (44.7) 28.4% (45.4) −1.3 (−16.9 – 14.4)
MADRS improvementb
6 months −5.3 (9.4) −4.3 (9.8) −1.1 (−4.4 – 2.3)
12 months −4.2 (9.6) −3.0 (10.8) −1.2 (−4.9 – 2.4)
PRIME-MD recoverya
6 months 60.4% (49.2) 41.6% (49.6) 18.8 (−0.22 – 37.8)
12 months 45.2% (50.1) 45.0% (50.1) 0.22 (−17.5 – 17.9)
QALY NLb
6 months 0.33 (0.13) 0.32 (0.14) 0.01 (−0.04 – 0.05)
12 months 0.66 (0.21) 0.65 (0.24) 0.02 (−0.06 – 0.09)
QALY UKb
6 months 0.31 (0.14) 0.30 (0.16) 0.01 (−0.04 – 0.06)
12 months 0.62 (0.24) 0.61 (0.28) 0.01 (−0.08 – 0.10)
a Percentage (SD).
b Mean (SD).
IPT, interpersonal therapy; CAU, care as usual; CI, confidence interval; MADRS, Montgomery Asberg
Depression Rating Scale; PRIME-MD, PRIMary care Evaluation of Mental Disorders; QALY NL =
quality-adjusted life-year based on Dutch tariff; QALY UK = quality-adjusted life-year based on British
tariff.
Table 2. Mean (SD) Total Costs (€) and Differences in Mean Total Costs (95% CI) during
Follow-up of 6 Months
Cost category IPT (n = 69) CAU (n = 74) Difference
Direct costs 1501 (1852) 821 (1267) 680 (−160 – 1298)
Direct healthcare costs 796 (1777) 780 (1263) 16 (−817 – 622)
Direct non-healthcare costs 49 (229) 41 (152) 8 (−64 – 94)
IPT costs 656 — —
Indirect costs 935 (3185) 538 (1850) 397 (−527 – 1335)
Lost productivity costs 680 (3007) 268 (1495) 411 (−405 – 1279)
Help from family/friends 256 (524) 270 (731) −14 (−256 – 202)
Total costs 2437 (3891) 1360 (2405) 1077 (−214 – 2234)
CI, confidence interval; IPT, interpersonal therapy; CAU, care as usual.
Table 3. Mean (SD) Total Costs (€) and Differences in Mean Total Costs (95% CI) during
Follow-up of 12 Months
Cost category IPT (n = 69) CAU (n = 74) Difference
Direct costs 3,980 (5,622) 3,423 (5,701) 557 (−2,219 – 2,803)
Direct healthcare costs 3,244 (5,504) 3,359 (5,670) −115 (−2,902 – 2,134)
Direct non-healthcare costs 80 (435) 64 (268) 16 (−119 – 158)
IPT costs 656 — —
Indirect costs 1,773 (3,942) 1,561 (3,753) 212 (−1,261 – 1,759)
Lost productivity costs 1,195 (3,728) 1,053 (3,354) 142 (−1,246 – 1,606)
Help from family/friends 578 (860) 508 (927) 70 (−327 – 387)
Total costs 5,753 (6,797) 4,984 (7,059) 769 (−2,459 – 3,433)
CI, confidence interval; IPT, interpersonal therapy; CAU, care as usual.
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Figure 1. Cost-effectiveness plane for the difference in recovery rates based on the PRImary care Evaluation of Mental
Disorders after 6 months.
€6,195 per extra recovered patient. Figure 1 presents the cost-
effectiveness plane for recovery based on the PRIME-MD at
6 months, in which 93 percent of the cost-effect pairs was lo-
cated in the northeast quadrant. At 12 months, the difference
in recovery rate had decreased to 0.2 percent, while the mean
total costs in the IPT group were €769 higher, resulting in an
ICER of 353,585. Most cost-effect pairs were located near
the origin of the cost-effectiveness plane and distributed over
all four quadrants, indicating that IPT was not cost-effective
compared with CAU (Figure 2).
For all other outcomes at 6 and 12 months (response
based on the MADRS, improvement in MADRS score, and
QALYs based on the British and Dutch EuroQol tariff), IPT
was not cost-effective in comparison with CAU.
Depression-Related Costs and
Cost-Effectiveness Analyses
The total mean (SD) depression-related costs at 12 months as
indicated by the patients themselves were€1,241 (2,870) and
€424 (1,309), respectively, in the IPT and the CAU groups.
The difference in total costs was €816, which was not sta-
tistically significant (95 percent CI, −151 – 1679). In none
of the cost-effectiveness and cost–utility analyses incorpo-
rating only depression-related costs IPT was cost-effective
in comparison with CAU.
DISCUSSION
In this study, the provision of IPT in primary care was not
cost-effective in comparison with CAU for elderly primary
care patients with major depression. At 6 months, there was a
large difference in recovery rate (PRIME-MD) between IPT
and CAU, but not in any of the other outcome measures. At
12 months, there were no significant differences in clinical
outcomes between IPT and CAU. Mean total costs in the
IPT group were higher than in the CAU group at both 6 and
12 months, but these cost differences were not statistically
significant. Although the difference in depression-related
costs between the two treatment groups was not statistically
significant, the relatively low depression-related costs in the
CAU group may indicate low rates of depression treatment
in this group.
Lave et al. (21) found in their study that IPT was signifi-
cantly more effective and expensive than usual care, whereas
we found no significant differences in either costs or effects.
In the study by Lave et al., patients were offered a maximum
of 20 IPT sessions by experienced therapists, whereas in our
study, patients were offered a maximum of ten IPT sessions
by less-experienced therapists. However, provision of IPT
by well-trained nurses improves the feasibility of incorpo-
rating psychotherapy in primary care. Finally, patients who
were included in the study by Lave et al. were more severely
depressed than the patients in our study. Katon et al. (17)
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Figure 2. Cost-effectiveness plane for the difference in recovery rates based on the PRImary care Evaluation of Mental
Disorders after 12 months.
evaluated the cost-effectiveness of a collaborative care pro-
gram incorporating problem-solving treatment (a brief psy-
chotherapy) for late-life depression in primary care. They
showed that the collaborative care program was more effec-
tive than usual care without significant cost increases. Thus
the (cost-)effectiveness of psychotherapy for elderly patients
in primary care may be improved by incorporation in a col-
laborative care program.
It is suggested that screening mostly leads to detection
of mildly depressed patients as opposed to patients who are
recognized as being depressed by their GP (12). This find-
ing was confirmed in our study. Despite that all patients
were diagnosed as having major depression according to the
PRIME-MD, most patients in our study were only mildly to
moderately depressed according to their MADRS scores at
baseline (18;24). It is likely that otherwise effective treat-
ments, such as antidepressants and psychotherapy, are not as
effective in mild depressions as in more severe depressions
because the room for improvement is limited. A study vali-
dating the MADRS as research instrument in older depressed
primary care patients, concluded that a MADRS score of
≥21 identifies depressed patients who need treatment (26).
Using this criterion, more than half of the patients included
in this study would have been too mildly depressed to benefit
from depression treatment.
The effects of IPT in comparison with CAU were some-
what larger at 6 months than at 12 months. It seems plausible
that IPT has more robust effects than CAU in the short-term,
but that this effect is diluted at 1-year follow-up, because
depression in elderly people often has a chronic and recur-
rent course (6). Future trials should, therefore, investigate
the optimal duration of IPT, and the effects of maintenance
treatments to sustain treatment effects gained in the acute
treatment phase. The effect of maintenance treatment was
already demonstrated in elderly secondary care patients with
a history of recurrent depression (31).
A considerable amount of cost diaries was missing in this
study. Recent studies have shown that simple procedures to
handle missing data, like complete case analysis, can bias the
cost estimates considerably and recommend MI to account
for missing cost and effect data (8;27), because MI incorpo-
rates the uncertainty caused by estimating the missing data
(33). Therefore, in this study we used MI to impute missing
cost data (27). We imputed different cost-categories at the
four different time points to use all available cost diaries.
Patients who returned no cost diaries were less depressed
than patients who returned more than one cost diary. In milder
depressions, there is less room for improvement, which leads
to smaller effects, but it is hard to indicate how this may influ-
ence the effect difference. We expect that milder depressed
patients have lower mean healthcare costs. Because the IPT
costs are high and, thus, weigh relatively heavier when the
overall costs are lower, we expect that the cost difference
stays equal or becomes larger.
Our study was underpowered to detect relevant differ-
ences in costs, which is reflected in wide confidence intervals
for cost differences. This is a common problem in “piggy
back” economic evaluations. Because the distribution of cost
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data typically is heavily skewed, very large numbers of study
patients are needed to detect relevant cost differences. It is
generally considered unethical to increase study sizes be-
yond the level needed to prove clinical effectiveness (7). De-
spite the low power of many economic evaluations, the focus
should be on estimation of cost-effectiveness even when ei-
ther cost or effect differences are not statistically significant.
The low power of the study will then be reflected in the wide
confidence intervals (7;9).
In conclusion, based on these results, provision of IPT to
elderly primary care patients with major depression who were
identified by screening, was not cost-effective in comparison
with CAU both at 6 and 12 months.
POLICY IMPLICATIONS
We recommend that future research focuses on patient groups
that may especially benefit from IPT in primary care, for ex-
ample patient selection based on the duration and severity
of depressive symptoms. Evidence is also needed on treat-
ments that have more robust effects, both in the acute and in
the maintenance phase of treatment. The cost-effectiveness
of psychotherapy in primary care may also be improved by
incorporating psychotherapy in collaborative care models.
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